MedCity’s INVEST and INVEST Digital Health events offer compelling forums for discussion around the healthcare innovation ecosystem and its components, from startups in health tech and life sciences, venture capital and strategic investors, healthcare…
Continue Reading
What You Should Know: – The healthcare venture capital landscape experienced a resurgence in the first half of 2024, according to a new report from Silicon Valley Bank (SVB). Despite ongoing economic challenges, 89%…
Continue Reading
Male-founded femtech firm Flo Health has called on investors to recognise the “vast potential” in the femtech space, following a viral debate about its unicorn status.
Flo announced in July 2024 that it had raised…
What You Should Know: – venBio, a leading life sciences venture capital firm, announced the successful closing of its fifth fund, venBio Fund V, with over $528M in capital commitments. – The new fund…
Continue Reading
The digital health fundraising environment has been a roller coaster over the past few years — soaring through the thrilling highs of rapid innovation and abundant capital, followed by the stomach-churning dips of market…
Continue Reading
Welcome to a new episode of Digital Health Interviews!Today, we dive into a brutally honest discussion about digital health with our guest, Sergei Polevikov. Sergei brings a wealth of experience and unfiltered insights into…
Continue Reading
The venture capital market seems to be truly normalizing following the highs and lows of the pandemic, which is good news to the thousands of healthcare startups out there vying for funding dollars.
Global venture…
Continue Reading
Seae Ventures, a firm that provides funding to early-stage healthcare technology and services companies, announced it acquired Unseen Capital, a fellow venture capital firm that invests in companies that address the challenges faced by…
Continue Reading
Amazon Web Services (AWS) announced it is collaborating with EvolutionaryScale, an AI company focused on biology, to give scientists and researchers access to the startup’s ESM3 language models via AWS to advance drug discovery…
Continue Reading
What You Should Know:
– Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
– The investment aims…
Continue Reading
